Valuation: Santen Pharmaceutical Co., Ltd.

Capitalization 548B 3.57B 3.02B 2.76B 2.64B 4.87B 324B 5.05B 32.15B 12.73B 156B 13.39B 13.11B P/E ratio 2026 *
16.8x
P/E ratio 2027 * 14.4x
Enterprise value 485B 3.15B 2.67B 2.44B 2.33B 4.31B 286B 4.47B 28.42B 11.25B 138B 11.83B 11.59B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.64x
Free-Float
94.58%
Yield 2026 *
2.24%
Yield 2027 * 2.46%
1 day-0.67%
1 week-1.43%
Current month-2.59%
1 month-3.23%
3 months+6.88%
6 months+7.02%
Current year+4.12%
1 week 1,676
Extreme 1676
1,743
1 month 1,665
Extreme 1665
1,790.5
Current year 1,626
Extreme 1626
1,790.5
1 year 1,310.5
Extreme 1310.5
1,790.5
3 years 999
Extreme 999
1,878.5
5 years 956
Extreme 956
1,878.5
10 years 956
Extreme 956
2,234
Manager TitleAgeSince
Chief Executive Officer 66 2022-08-31
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman 73 2024-03-31
Director/Board Member 69 2022-06-23
Director/Board Member 70 2024-05-31
Change 5d. change 1-year change 3-years change Capi.($)
-0.67%-1.43%+24.81%+68.29% 3.57B
-0.38%+1.08%+22.72%+215.48% 926B
-0.05%+2.09%+55.83%+51.71% 586B
+0.59%+4.68%+20.73%+53.90% 412B
-0.07%+3.31%+24.99%+31.62% 382B
+0.67%+5.68%+32.85%+35.70% 326B
+0.45%+4.74%+34.08%+61.46% 317B
+0.13%+3.77%+46.45%+11.00% 302B
-0.50%+0.20%-47.65%-37.52% 218B
+1.13%+2.39%+28.23%+55.22% 201B
Average -0.06%+2.71%+24.30%+54.69% 367.28B
Weighted average by Cap. +0.10%+2.94%+27.97%+82.13%

Financials

2026 *2027 *
Net sales 290B 1.89B 1.6B 1.46B 1.4B 2.58B 171B 2.68B 17.03B 6.74B 82.66B 7.09B 6.94B 294B 1.91B 1.62B 1.48B 1.42B 2.61B 174B 2.71B 17.25B 6.83B 83.71B 7.18B 7.03B
Net income 33.19B 216M 183M 167M 160M 295M 19.59B 306M 1.95B 771M 9.45B 810M 794M 37.6B 245M 207M 189M 181M 334M 22.19B 346M 2.2B 873M 10.7B 918M 899M
Net Debt -63.68B -415M -351M -320M -306M -566M -37.58B -587M -3.73B -1.48B -18.13B -1.55B -1.52B -66.01B -430M -363M -332M -318M -587M -38.95B -608M -3.87B -1.53B -18.79B -1.61B -1.58B
Logo Santen Pharmaceutical Co., Ltd.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
Employees
3,849
Calendar
Date Price Change Volume
26-02-18 1,693.00 ¥ -0.67% 878,800
26-02-17 1,704.50 ¥ -0.47% 536,400
26-02-16 1,712.50 ¥ -0.44% 850,400
26-02-13 1,720.00 ¥ +0.15% 872,500
26-02-12 1,717.50 ¥ -0.58% 769,700
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1,704.50JPY
Average target price
2,147.78JPY
Spread / Average Target
+26.01%

Quarterly revenue - Rate of surprise